CaraAEastMDFACP FAPCR
Cardiology • Dallas, TXEchocardiography, Non-Invasive Cardiology, Preventive Cardiology
Professor, Internal Medicine, TX A&M Univ Coll of Med
Dr. East is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
621 N Hall St
Dallas, TX 75226Phone+1 214-820-2273Fax+1 214-820-6236
Summary
- I am a board-certified cardiologist with interest in clinical research and echocardiography. I lead a clinical research organization three days a week and see patients one day a week. I am available by phone anytime.
Education & Training
Baylor University Medical CenterFellowship, Cardiovascular Disease, 1988 - 1990
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1987- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1981 - 1984
University of Texas Southwestern Medical SchoolClass of 1981
Certifications & Licensure
TX State Medical License 1981 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study Start of enrollment: 2015 Jun 01
- Alirocumab in Patients on a Stable Dialysis Regimen Start of enrollment: 2018 May 01
Publications & Presentations
PubMed
- 774 citationsEffect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, pla...Paul M. Ridker, Jean G. MacFadyen, Tom Thuren, Brendan M. Everett, Peter Libby
Lancet. 2017-10-21 - 113 citationsIxmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trialAmit N. Patel, Timothy D. Henry, Arshed A Quyyumi, Gary L. Schaer, R. David Anderson
Lancet. 2016-06-11 - 565 citationsRelationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised co...Paul M. Ridker, Jean G. MacFadyen, Brendan M. Everett, Peter Libby, Tom Thuren
Lancet. 2017-11-13
Press Mentions
Cholesterol Disorder May Affect Millions of Unsuspecting Children and AdultsFebruary 22nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
